Bisindolylmaleimide VIII
CAS No. 125313-65-7
Bisindolylmaleimide VIII ( —— )
产品货号. M36363 CAS No. 125313-65-7
Bisindolylmaleimide VIII (Ro-31-7549) is a selective and potent protein kinase C (PKC) inhibitor with good inhibition of PKC-α, PKC-β I, PKC-β II, PKC-γ, and PKC-ε.Bisindolylmaleimide VIII Bisindolylmaleimide VIII inhibits T cell-mediated autoimmune diseases and enhances Fas-mediated apoptosis through a protein kinase C-independent mechanism.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥4674 | 有现货 |
|
| 10MG | ¥6774 | 有现货 |
|
| 25MG | ¥9858 | 有现货 |
|
| 50MG | ¥13206 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Bisindolylmaleimide VIII
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Bisindolylmaleimide VIII (Ro-31-7549) is a selective and potent protein kinase C (PKC) inhibitor with good inhibition of PKC-α, PKC-β I, PKC-β II, PKC-γ, and PKC-ε.Bisindolylmaleimide VIII Bisindolylmaleimide VIII inhibits T cell-mediated autoimmune diseases and enhances Fas-mediated apoptosis through a protein kinase C-independent mechanism.
-
产品描述Bisindolylmaleimide VIII (Ro-31-7549) is a selective and potent protein kinase C (PKC) inhibitor with good inhibition of PKC-α, PKC-β I, PKC-β II, PKC-γ, and PKC-ε.Bisindolylmaleimide VIII Bisindolylmaleimide VIII inhibits T cell-mediated autoimmune diseases and enhances Fas-mediated apoptosis through a protein kinase C-independent mechanism.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Angiogenesis
-
靶点PKC
-
受体PKC | Apoptosis
-
研究领域——
-
适应症——
化学信息
-
CAS Number125313-65-7
-
分子量398.46
-
分子式C24H22N4O2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C1NC(=O)C(C2=CN(C=3C=CC=CC23)CCCN)=C1C4=CN(C=5C=CC=CC45)C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
ζ-Stat
ze-Stat(1,3,6-萘三磺酸)是一种新型 PKC-zeta (PKC-ze) 特异性抑制剂,IC50 为 5 uM。
-
PKCiota-IN-51
PKCiota-IN-51 是一种有效的选择性蛋白激酶 C iota (PKC-ι) 抑制剂,IC50 为 2.7 nM。
-
PKC-iota inhibitor 1
PKC-iota抑制剂1是蛋白激酶C-iota的抑制剂(PKC-ι;IC50:0.34 μM)。
021-51111890
购物车()
sales@molnova.cn

